MORPHEUS: A phase Ib/II trial platform evaluating the safety and efficacy of multiple cancer immunotherapy (CIT) combinations in patients (pts) with gastric or pancreatic cancer.

Do-Youn Oh,Salah-Eddin Al-Batran,Hyun Cheol Chung,Antoine Hollebecque,Syma Iqbal,Kyu Pyo Kim,Jill Lacy,Gulam Abbas Manji,Eileen Mary OReilly,Osama E. Rahma,Harry H. Yoon,Antonia Kwan,Xian He,Hila Barak,Pakeeza Sayyed,Xiaosong Zhang,Jun Wang,Edward Cha,Tanios S. Bekaii-Saab

MORPHEUS: A phase Ib/II trial platform evaluating the safety and efficacy of multiple cancer immunotherapy (CIT) combinations in patients (pts) with gastric or pancreatic cancer.

2018

Do-Youn Oh
Salah-Eddin Al-Batran
Hyun Cheol Chung
Antoine Hollebecque
Syma Iqbal
Kyu Pyo Kim
Jill Lacy
Gulam Abbas Manji
Eileen Mary OReilly
Osama E. Rahma
Harry H. Yoon
Antonia Kwan
Xian He
Hila Barak
Pakeeza Sayyed
Xiaosong Zhang
Jun Wang
Edward Cha
Tanios S. Bekaii-Saab

TPS4134Background: Multiple cancers have been treated successfully with CIT; nonetheless, only subsets of pts experience durable response with CIT monotherapy. CIT combinations may therefore be nee...

Keywords:

Pancreatic cancer
Multiple cancer
Oncology
Pathology
Immunotherapy
Internal medicine
Medicine
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations